Ars Technica11:49 AM

Bad cholesterol slashed 62% by single dose of gene-editing drug in small trial

Bad cholesterol slashed 62% by single dose of gene-editing drug in small trial

The interim Phase I trial data was only from 35 people, but results look good so far.

Read original

More in this edition

10 stories

Older stories and past days

Browse saved daily editions in the public archive.

Browse past days